Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Healthcare Medical Devices
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp
Bullboard Posts
User Avatar Image
(0)
•••
Post by Dojitrader15on Aug 29, 2016 1:38pm
113 Views
Post# 25187637

MDX Posts Q2 Loss

MDX Posts Q2 LossTSXV-Listed MedX Health Corp Posts Q2 Loss of $311K

08/26/2016 01:19 PM ET

01:19 PM EDT, 08/26/2016 (MT Newswires) -- MedX Health Corp. (MDX.V) reported revenue of $209,496 for the three months ended June 30, 2016, compared with revenue of $367,256 for the three months ended June 30, 2015. The Company had a loss for the three months ended June 30, 2016 of $310,869, or $0.00 per share compared with a loss of $50,609, or $0.00 per share for the three months ended June 30, 2015. The loss in 2015 was reduced due to one-time cost reversals of $114,000.

Price: 0.085, Change: 0, Percent Change: 0

https://www.mtnewswires.com
Copyright © 2016 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities